Phoenix, AZ, United States of America

David Alexandro Medina

This inventor holds 1 USPTO granted patent. Top assignee: Dignity Health. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Alexandro Medina. Retrieved from https://idiyas.com/inventor/david-alexandro-medina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by David Alexandro Medina in Drug Delivery Systems

Introduction

David Alexandro Medina is an innovative inventor based in Phoenix, AZ. He has made significant contributions to the field of drug delivery systems, particularly through his research on nanoparticle compositions. His work focuses on addressing neurological diseases and enhancing treatment efficacy.

Latest Patents

David Alexandro Medina holds a patent for "Nanoparticle compositions, methods of fabrication, and use for drug delivery." This invention relates to a composition that utilizes retinoid encapsulated in nanoparticles. The nanoparticles are designed to increase lifespan and provide neuroprotective effects, such as preserving motor units, reducing motor impairment, and minimizing neuroinflammation in subjects.

Career Highlights

Medina is currently employed at Dignity Health, where he continues to explore innovative solutions in healthcare. His work is pivotal in advancing therapeutic methods for neurological disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Some of his notable coworkers include Rachael Sirianni and Eugene Chung, who contribute to the collaborative environment at Dignity Health.

Conclusion

David Alexandro Medina's contributions to drug delivery systems through his innovative patent highlight his role as a key inventor in the field. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…